Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.15844 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.1393 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.14026 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.13874 | 8 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.13778 | 8 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.19007 | 7 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.16269 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.12366 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.11913 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.13558 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.12374 | 7 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.12186 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.13218 | 7 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.13084 | 7 |